About
CLICK HERE for more information on Durbin EAPs and to access valuable resources.
Durbin has been running Expanded Access Programs (EAPs) and worldwide named patient sales programs for pharmaceutical and biotech companies for over 25 years.
Our expert teams have extensive knowledge and experience in navigating complex global regulatory pathways to ensure the compliant and timely supply of unlicensed medicines. Durbin can support all forms of expanded or managed access, including compassionate use, named patient supply, cohort programs, and single patient access. Durbin’s unique combination of world class global distribution capabilities, innovative ‘uniphi’ technology, and passionate, experienced teams of expanded access specialists ensure you are in safe hands when entrusting your global EAP to Durbin.
